Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

influenza vaccine (live attenuated, nasal)

FLUENZ TETRA

influenza vaccine (live attenuated, nasal) (FLUENZ TETRA) is an FDA-listed pharmaceutical active ingredient.

EMA: approved Antiinfectives for systemic use (J07) J07BB03
Patents linked 20
Pipeline programs 112
News articles 0
Drug details — influenza vaccine (live attenuated, nasal)
Class
Antiinfectives for systemic use (J07)
Route
—
Patents
20
Programs
112
Data quality
0.83
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

influenza vaccine (live attenuated, nasal) (FLUENZ TETRA) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN influenza vaccine (live attenuated, nasal)
Brand FLUENZ TETRA
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07BB03

Approval history

Authority Status Date
EMA approved —

Pipeline programs

Browse pipeline
  1. APHP210090 Phase 3 · PARItec · Adult patients admitted to the ICU for management of severe
  2. Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) Phase 3 · Seqirus USA · Influenza Virus
  3. Baloxavir Marboxil Phase 3 · HOFFMANN-LA ROCHE · Influenza
  4. COMB157G2399 Phase 3 · Novartis India · Relapsing multiple sclerosis (RMS)
  5. Ceftriaxone Phase 3 · Adaptive Biotechnologies · Community-acquired Pneumonia, Influenza, COVID-19
  6. FLUDEX Phase 3 · George Institute for · Severe Influenza
  7. FluLaval® Quadrivalent Phase 3 · GSK Glaxo Smith · Influenza
  8. Flublok Quadrivalent vaccine Phase 3 · Hospital Authority · Influenza Vaccination

Related & competitor drugs

Browse all drugs
  1. atazanavir sulfate Antiinfectives for systemic use (J05)
  2. colistimethate sodium Antiinfectives for systemic use (J01)
  3. covid-19 mrna vaccine Antiinfectives for systemic use (J07)
  4. daptomycin Antiinfectives for systemic use (J01)
  5. darunavir Antiinfectives for systemic use (J05)
  6. dengue tetravalent vaccine (live, attenuated) Antiinfectives for systemic use (J07)

Related patents

Browse patents

  1. US 12398379

    Compositions and methods for treating ornithine transcarbamylase deficiency

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12390524

    Compositions and methods for inducing immune responses

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. WO 2025114430

    COMPOSITION À LIBÉRATION MODIFIÉE

    Expires Wed May 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12290567

    Asialoglycoprotein Receptor mediated delivery of therapeutically active conjugates

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12286395

    Method of synthesis of an ionizable cationic lipid

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12268737

    Stabilized influenza hemagglutinin stem region trimers and uses thereof

    Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12251561

    Minimally invasive dermal electroporation device

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12234263

    Influenza vaccines

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12220453

    Compositions and treatments for Haemophilus influenzae

    Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12220485

    Method of making lipid-encapsulated RNA nanoparticles

    Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. WO 2025030001

    PROCÉDÉS ET COMPOSITIONS POUR LE MAINTIEN DE LA MOBILITÉ ET/OU DE LA MASSE DES MUSCLES SQUELETTIQUES, ET/OU POUR LA RÉCUPÉRATION DE LA FORCE DES MUSCLES SQUELETTIQUES

    Expires Wed Feb 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12178921

    Method of lyophilizing lipid nanoparticles

    Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. WO 2024206551

    COMPOSITIONS ET PROCÉDÉS DE RÉHYDRATATION D'ALGUES MARINES

    Expires Wed Sep 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 12083224

    Lipid particles for nucleic acid delivery

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11975063

    Recombinant chimeric bovine/human parainfluenza virus 3 expressing rsv g and its use

    Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11969466

    Stabilized influenza hemagglutinin stem region trimers and uses thereof

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. WO 2024064327

    OLIGOSACCHARIDES DE LAIT HUMAIN POUR AMÉLIORER LA FONCTION DE BARRIÈRE HÉMATO-ENCÉPHALIQUE

    Expires Wed Mar 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11939600

    Compositions and methods for treating phenylketonuria

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11939363

    Translatable molecules and synthesis thereof

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11938227

    Lipid nanoparticles encapsulation of large RNA

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is influenza vaccine (live attenuated, nasal)?

influenza vaccine (live attenuated, nasal) (FLUENZ TETRA) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for influenza vaccine (live attenuated, nasal)?

FLUENZ TETRA is a marketed brand name for influenza vaccine (live attenuated, nasal). Check FDA Drugs@FDA for the current US label holder and prescribing information.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.